Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Device-Based Strategies for Guideline-Directed Therapy in Heart Failure
Author(s): Renzo Laborante , Attilio Restivo , Daniela Mele , et al Added: 1 week ago

Heart Failure

Prevention & Chronic Conditions
New 2025 Guideline for the Management of Acute Coronary Syndromes
Author(s): Sunil V Rao Added: 1 month ago
Since the last update in 2013, what changes have been made to the new guidelines for managing acute coronary syndromes?In this short interview, Dr Sunil Rao (NYU Grossman School of Medicine, New York, US) discusses the new 2025 guideline for the management of acute coronary syndromes released by the AHA and ACC joint committee. The current guideline was informed by a number of clinical trials… View more

MI/ACS
ESC 23: The PUSH-AHF Study
Author(s): Jozine ter Maaten Added: 1 year ago
ESC 2023 — Dr Jozine Ter Maaten (University Medical Centre Groningen, NL) joins us to outline the findings from the PUSH-AHF Study (NCT04606927). PUSH-AHF (University Medical Center Groningen) aimed to assess the effect of natriuresis-guided therapy in patients with acute heart failure to improve diagnostic response, decongestion and clinical outcomes. 310 patients with a primary diagnosis of… View more

Heart Failure
Biomarkers to Improve Decision-making in Acute Heart Failure
Author(s): Rafael de la Espriella , Gonzalo Núñez-Marín , Pau Codina , et al Added: 1 year ago

Guidelines & Statements

Heart Failure
2023 ESC Guidelines Update: Acute & Chronic Heart Failure
Author(s): Giuseppe Rosano , Harriette Van Spall Added: 1 year ago
ESC 23 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Giuseppe Rosano (St George’s Hospitals NHS Trust University of London, UK), President of HFA to distil the key messages from the 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Prof Rosano summarises the retained ejection fraction… View more

Guidelines & Statements

Heart Failure
‘Residual Congestion’ in HF
Author(s): Aleksandra Gasecka , Aleksander Siniarski Added: 1 month ago

Heart Failure

Imaging & Diagnostics
THT 2025: The FASTR Trial
Author(s): James Udelson Added: 3 months ago
THT Conference 2025 - Positive safety and efficacy outcomes were found of the Reprieve decongestion management system (DMS; Reprieve Cardiovascular, Inc) for the treatment of acute decompensated heart failure (ADHF). Urinary sodium excretion was seen to be significantly higher in the Reprieve DMS arm than in the control arm, and there were fewer UTI infections in ADHF patients receiving the… View more

Heart Failure
ACC 2025: The CardiAMP-HF Trial
Author(s): Amish Raval Added: 1 month ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the… View more

Heart Failure
Guideline-directed Medical Therapy is the Most Effective Decongestion
Author(s): Jelena Celutkiene , Alexandre Mebazaa , Jan Biegus , et al Added: 3 months ago

Heart Failure
Red Flags in Acute Myocarditis
Author(s): Shahrukh Hashmani , Yosef Manla , Nadya Al Matrooshi , et al Added: 1 year ago

Imaging & Diagnostics

Heart Failure